ArticlePlant physiology2026
Discovery of regulatory complexes in Arabidopsis via protein-metabolite mapping during Pseudomonas infection.
Article in Plant physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Protein-metabolite interactions (PMIs) are critical regulators of cellular processes, yet their roles in plant-pathogen interactions remain poorly understood. Here, we applied PROMIS (Protein-Metabolite Interactions using Size separation) to map the Arabidopsis protein-metabolite interactome during infection with Pseudomonas syringae pv. tomato DC3000 (Pto DC3000). PROMIS resolved elution profiles for >5,700 proteins and 192 annotated metabolites across infected, systemic, and control tissues, revealing infection-associated remodeling of protein assemblies and metabolite co-fractionation patterns. Integrating co-fractionation with coronatine-induced transcriptional responses, we identified NATA1, a polyamine N-acetyltransferase, as a coronatine-associated host protein binder. Biochemical assays confirmed direct coronatine-NATA1 interaction (Kd = 586 nm), whereas the homolog NATA2 did not bind coronatine. Coronatine did not strongly inhibit NATA1 catalytic turnover under our assay conditions but consistently depressed NATA1 dimer formation in vitro and in planta. In silico docking together with targeted mutational analyses identified a coronatine-sensitive interface on NATA1, revealing residue-specific coupling between ligand binding, assembly state, and acetyl-CoA engagement. Collectively, these findings establish PROMIS as a robust platform for infection-state PMI discovery and uncover a coronatine-responsive regulatory node that links small-molecule signaling to host polyamine acetylation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.